160 related articles for article (PubMed ID: 38443633)
1. Clinical Investigation of Large Volume Subcutaneous Delivery up to 25 mL for Lean and Non-Lean Subjects.
Dang X; Shih H; Sharma R; Angwin-Kaerner DT; Lin K; Kapur S; Thyagarajapuram NR; Shi GH; Collins DS
Pharm Res; 2024 Apr; 41(4):751-763. PubMed ID: 38443633
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults.
Woodley WD; Morel DR; Sutter DE; Pettis RJ; Bolick NG
Clin Transl Sci; 2022 Jan; 15(1):92-104. PubMed ID: 34268888
[TBL] [Abstract][Full Text] [Related]
3. Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.
Dias C; Abosaleem B; Crispino C; Gao B; Shaywitz A
AAPS PharmSciTech; 2015 Oct; 16(5):1101-7. PubMed ID: 25693652
[TBL] [Abstract][Full Text] [Related]
4. A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers.
Portron A; Jordan P; Draper K; Muenzer C; Dickerson D; van Iersel T; Hofmann C
Clin Ther; 2020 Jan; 42(1):108-120.e1. PubMed ID: 31883703
[TBL] [Abstract][Full Text] [Related]
5. Understanding Subcutaneous Tissue Pressure for Engineering Injection Devices for Large-Volume Protein Delivery.
Doughty DV; Clawson CZ; Lambert W; Subramony JA
J Pharm Sci; 2016 Jul; 105(7):2105-13. PubMed ID: 27287520
[TBL] [Abstract][Full Text] [Related]
6. Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects.
Woodley WD; Yue W; Morel DR; Lainesse A; Pettis RJ; Bolick NG
Clin Transl Sci; 2021 May; 14(3):859-869. PubMed ID: 33278331
[TBL] [Abstract][Full Text] [Related]
7. A patient care program for adjusting the autoinjector needle depth according to subcutaneous tissue thickness in patients with multiple sclerosis receiving subcutaneous injections of glatiramer acetate.
Masid ML; Ocaña RH; Gil MJ; Ramos MC; Roig ME; Carreño MR; Morales JC; Carrasco ML; Hidalgo LM; Felices AM; Castaño AH; Romero PC; Martinez PF; Sánchez-De la Rosa R
J Neurosci Nurs; 2015 Feb; 47(1):E22-30. PubMed ID: 25225835
[TBL] [Abstract][Full Text] [Related]
8. Tezepelumab Pharmacokinetics, Safety, and Tolerability After Administration via Vial-and-syringe, Accessorized Prefilled Syringe, or Autoinjector: A Randomized Trial in Healthy Volunteers.
Zheng Y; Abuqayyas L; Megally A; Fuhr R; Sałapa K; Downie J; Colice G
Clin Ther; 2021 Jan; 43(1):142-155.e5. PubMed ID: 33380362
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries.
Mathaes R; Koulov A; Joerg S; Mahler HC
J Pharm Sci; 2016 Aug; 105(8):2255-9. PubMed ID: 27378678
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers.
Berteau C; Schwarzenbach F; Donazzolo Y; Latreille M; Berube J; Abry H; Cotten J; Feger C; Laurent PE
Patient Prefer Adherence; 2010 Oct; 4():379-88. PubMed ID: 21049090
[TBL] [Abstract][Full Text] [Related]
11. A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation.
Halpern V; Wheeless A; Brache V; Lendvay A; Cochón L; Taylor D; Dorflinger LJ
Contracept X; 2023; 5():100100. PubMed ID: 37823034
[TBL] [Abstract][Full Text] [Related]
12. An Innovative Needle-free Injection System: Comparison to 1 ml Standard Subcutaneous Injection.
Kojic N; Goyal P; Lou CH; Corwin MJ
AAPS PharmSciTech; 2017 Nov; 18(8):2965-2970. PubMed ID: 28462463
[TBL] [Abstract][Full Text] [Related]
13. Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
Singer B; Bandari D; Cascione M; LaGanke C; Huddlestone J; Bennett R; Dangond F;
BMC Neurol; 2012 Dec; 12():154. PubMed ID: 23216674
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
[TBL] [Abstract][Full Text] [Related]
15. Novel cannula design improves large volume auto-injection rates for high viscosity solutions.
Roberts BC; Rini C; Klug R; Sherman DB; Morel D; Pettis RJ
Drug Deliv; 2022 Dec; 29(1):43-51. PubMed ID: 34962225
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous Injection Performance in Yucatan Miniature Pigs with and without Human Hyaluronidase and Auto-injector Tolerability in Humans.
Shi GH; Connor RJ; Collins DS; Kang DW
AAPS PharmSciTech; 2021 Jan; 22(1):39. PubMed ID: 33409604
[TBL] [Abstract][Full Text] [Related]
17. Advances in Large Volume Subcutaneous Injections: A Pilot Tolerability Study of an Innovative Needle-Free Injection Platform.
Kelley EL; Fernandes A; Pelletier M; Takami EA; Emery C; Dyer B; Jacoski MV; Lozko V; Burgess B; Smith RH
PDA J Pharm Sci Technol; 2022; 76(6):474-484. PubMed ID: 35296562
[TBL] [Abstract][Full Text] [Related]
18. Short communication safety, tolerability and pharmacokinetics of enfuvirtide administered by a needle-free injection system compared with subcutaneous injection.
Gottlieb M; Thommes JA;
Antivir Ther; 2008; 13(5):723-7. PubMed ID: 18771056
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance.
Berteau C; Filipe-Santos O; Wang T; Rojas HE; Granger C; Schwarzenbach F
Med Devices (Auckl); 2015; 8():473-84. PubMed ID: 26635489
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous administration of midazolam: a comparison of the Bioject jet injector with the conventional syringe and needle.
Bennett J; Nichols F; Rosenblum M; Condry J
J Oral Maxillofac Surg; 1998 Nov; 56(11):1249-54. PubMed ID: 9820211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
